Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer

被引:0
作者
Linda Ye
Dennis Rünger
Stephanie A. Angarita
Joseph Hadaya
Jennifer L. Baker
Minna K. Lee
Carlie K. Thompson
Deanna J. Attai
Maggie L. DiNome
机构
[1] David Geffen School of Medicine at UCLA,Department of Surgery
[2] David Geffen School of Medicine at UCLA,Statistics Core, Department of Medicine
[3] Memorial Sloan Kettering Cancer Center,Department of Surgery
[4] Duke University School of Medicine,Department of Surgery
来源
Breast Cancer Research and Treatment | 2022年 / 193卷
关键词
Nodal stage; Palpable adenopathy; Clinically node-positive; Breast cancer; Axillary lymph node dissection; Sentinel node biopsy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:429 / 436
页数:7
相关论文
共 82 条
[1]  
Boughey JC(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positivie breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 1455-1461
[2]  
Suman VJ(2015)Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study J Clin Oncol 33 258-264
[3]  
Mittendorf EA(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA a prospective multicentre cohort study Lancet Oncol 14 609-618
[4]  
Boileau JF(2014)Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial Ann Surg 260 608-616
[5]  
Poirier B(2014)Pathologic complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 164-172
[6]  
Basik M(2011)Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Breast Cancer Res Treat 125 145-156
[7]  
Kuehn T(2020)How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast-conserving surgery? Ann Surg Oncol 27 4702-4710
[8]  
Banenfeind I(2020)Axillary response in patients undergoing neoadjuvant endocrine treatment for node-positive breast cancer: systematic literature review and NCDB analysis Ann Surg Oncol 27 4669-4677
[9]  
Fehm T(2011)Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 569-575
[10]  
Boughey JC(2014)Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Lancet Oncol 15 1303-1310